Dr. Girish Dhall, MD
Claim this profileChildren's Hospital of Alabama
About Girish Dhall, MD
Education:
- Obtained MD from the University of Alabama at Birmingham School of Medicine in 2006.
- Completed Residency in Pediatrics at the University of Alabama at Birmingham in 2009.
- Finished Fellowship in Pediatric Hematology/Oncology at the University of Alabama at Birmingham in 2012.
Experience:
- Associate Professor of Pediatrics and Director of the Neuro-Oncology Program at the Children's Hospital of Alabama.
Area of expertise
Brain Tumor
Girish Dhall, MD has run 8 trials for Brain Tumor. Some of their research focus areas include:
Brain Cancer
Girish Dhall, MD has run 7 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Children's Hospital Of Alabama
University Of Alabama At Birmingham
Clinical Trials Girish Dhall, MD is currently running
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting
1 award
Phase 1 & 2
1 criteria
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting
1 award
Phase 1 & 2
13 criteria
More about Girish Dhall, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Girish Dhall, MD has experience with
- Radiation Therapy
- Vincristine
- Nivolumab
- Cyclophosphamide
- Lomustine
- Fludarabine
Breakdown of trials Girish Dhall, MD has run
Brain Tumor
Brain Cancer
Solid Tumors
Malignant Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Girish Dhall, MD specialize in?
Girish Dhall, MD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved Stage I patients, or patients who are Stage II.
Is Girish Dhall, MD currently recruiting for clinical trials?
Yes, Girish Dhall, MD is currently recruiting for 10 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Girish Dhall, MD has studied deeply?
Yes, Girish Dhall, MD has studied treatments such as Radiation Therapy, Vincristine, Nivolumab.
What is the best way to schedule an appointment with Girish Dhall, MD?
Apply for one of the trials that Girish Dhall, MD is conducting.
What is the office address of Girish Dhall, MD?
The office of Girish Dhall, MD is located at: Children's Hospital of Alabama, Birmingham, Alabama 35233 United States. This is the address for their practice at the Children's Hospital of Alabama.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.